期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Brain Tumours and Prophylactic Antiepileptic Drug Prescribing Patterns by Neurosurgeons Practising in Australasia 认领
1
作者 Chrisovalantis A. Tsimiklis Marguerite A. Harding 《神经系统科学与医药(英文)》 2015年第1期13-19,共7页
Prescribing patterns amongst practising Australasian neurosurgeons regarding the use of prophylactic antiepileptic drugs (AEDs) in patients with newly diagnosed intrinsic brain tumours are not well established. This s... Prescribing patterns amongst practising Australasian neurosurgeons regarding the use of prophylactic antiepileptic drugs (AEDs) in patients with newly diagnosed intrinsic brain tumours are not well established. This study aimed to determine the rate of prophylactic AED prescribing in this clinical context and to determine if there were some particular factors that influenced prescribers in their decision. A survey was conducted, and of the 91 respondents, 23 (25.3%) prescribed prophylactic AEDs. No neurosurgeons practising in New Zealand prescribed, whereas within Australian states/territories, prescribing was most common in Western Australia (3/4, 75.0%) and Queensland (8/18, 44.4%) and less common in the Australian Capital Territory (0/2, 0.0%) and South Australia (1/7, 14.3%). The most commonly prescribed first-line AED was phenytoin (n = 15, 68.2%) followed by levetiracetam (n = 5, 22.7%). The duration of prescription varied from 1 week to 6 months, with 6 weeks chosen by most prescribers (n = 7, 35%). Important factors that influence the decision to prescribe include tumour location and a history of previous seizure/s, whereas the presence of oedema or haemorrhage and patients’ age do not seem to be major influences amongst prescribers. 展开更多
关键词 Brain Tumours ANTIEPILEPTIC Drugs SEIZURE PROPHYLAXIS Medication PRESCRIBING
在线阅读 下载PDF
英国非医疗处方权管理及对我国的启示 认领
2
作者 刘秋风 沈夕坤 +2 位作者 田侃 喻小勇 刘雪竹 《中国药房》 CAS 北大核心 2018年第20期2742-2746,共5页
目的:系统了解英国非医疗处方权的管理模式,为我国非医疗处方权的建立和实施提供启示。方法:通过查阅国内外文献,对英国非医疗处方权的发展历程、类型、核心要素、实施现状及效果进行系统介绍,并对我国非医疗处方权模式的发展提出... 目的:系统了解英国非医疗处方权的管理模式,为我国非医疗处方权的建立和实施提供启示。方法:通过查阅国内外文献,对英国非医疗处方权的发展历程、类型、核心要素、实施现状及效果进行系统介绍,并对我国非医疗处方权模式的发展提出建议。结果与结论:英国于1994年开始实行非医疗处方权,经过多年的实践与一系列立法及修订,到2012年,独立处方权者(包括护士和药师)拥有为患者开具任何药品的法定权利。英国的非医疗处方权分为主要存在于社区药房中、限于特定疾病种类的独立处方权(包括护士独立处方权、药师独立处方权)和存在于医院或诊所、需要和医生等签订合作协议的补充处方权。其管理机构主要由一个国家行政部门(英国卫生部)和三个专业协会(英国护理和助产理事会、英国皇家药物协会、北爱尔兰制药学会)组成,其对处方权者的资质和相应责任有着详细、严格的规定。英国政府为非医疗处方权模式的发展提供了法律保障,非医疗处方权者数量也在不断增加,这一模式的实施能够增加患者获得医疗服务的机会。借鉴英国非医疗处方权管理的发展经验,我国需通过完善立法、为非医疗处方权的实施提供法律保障,扩大我国护士和药师的实践范围,建立健全非医疗处方权专业人才培养计划等措施,以促进我国非医疗处方权模式的发展。 展开更多
关键词 非医疗处方权 英国 护士 药师 启示
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部 意见反馈